Glenmark Pharmaceuticals Ltd. has reported a net loss in the third quarter of fiscal 2024, missing analysts' estimates.
Shares of Glenmark Pharma ended 4.35% lower ahead of the results announcement on Wednesday, as compared with a 0.45% rise in the benchmark NSE.
WRITTEN BY
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
Paytm Q2 Results: Profit Slumps As Exceptional Loss Weighs, Revenue Up 7.5%
Urban Company Q2 Results: Net Loss Widens Even As Revenue Surges 37%
Ixigo Slips Into Red, Reports Rs 3.46 Crore Loss In Q2
Diwali Muhurat Stock Picks: Nykaa, Swiggy, SBI, Bajaj Finance Among LKP's Top Recommendations
POPULAR
1
Q2 Results Live: Saregama India Net Profit Down 2.5%, Delhivery, Britannia To Report Results Soon
2
India Unveils AI Governance Framework, Opts For ‘Light-Touch’ Oversight
3
Housing Prices Appreciate 7-19% In Jul-Sep Across Top 8 Cities: PropTiger
4
Navi Mumbai Police Bust Trading Fraud With Links To China, Cambodia; 7 Held
5